Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 1
2012 1
2013 4
2014 1
2015 1
2016 2
2017 1
2019 3
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Antigenicity and immune correlate assessment of seven Plasmodium falciparum antigens in a longitudinal infant cohort from northern Ghana.
Kusi KA, Aguiar J, Kumordjie S, Aggor F, Bolton J, Renner A, Kyei-Baafour E, Puplampu N, Belmonte M, Dodoo D, Gyan BA, Ofori MF, Oduro AR, Atuguba F, Koram KA, Adams N, Letizia A, Villasante E, Sedegah M. Kusi KA, et al. Sci Rep. 2019 Jun 13;9(1):8621. doi: 10.1038/s41598-019-45092-4. Sci Rep. 2019. PMID: 31197225 Free PMC article.
Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana.
Kusi KA, Manu EA, Manful Gwira T, Kyei-Baafour E, Dickson EK, Amponsah JA, Remarque EJ, Faber BW, Kocken CHM, Dodoo D, Gyan BA, Awandare GA, Atuguba F, Oduro AR, Koram KA. Kusi KA, et al. PLoS One. 2017 Sep 25;12(9):e0185303. doi: 10.1371/journal.pone.0185303. eCollection 2017. PLoS One. 2017. PMID: 28945794 Free PMC article.
Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study.
Koram KA, Adu B, Ocran J, Karikari YS, Adu-Amankwah S, Ntiri M, Abuaku B, Dodoo D, Gyan B, Kronmann KC, Nkrumah F. Koram KA, et al. PLoS One. 2016 Sep 19;11(9):e0163066. doi: 10.1371/journal.pone.0163066. eCollection 2016. PLoS One. 2016. PMID: 27644034 Free PMC article. Clinical Trial.
Non-malaria fevers in a high malaria endemic area of Ghana.
Asante KP, Owusu-Agyei S, Cairns M, Boamah E, Manu G, Twumasi M, Gyasi R, Adjei G, Kayan K, Mahama E, Dosoo DK, Koram K, Greenwood B, Chandramohan D. Asante KP, et al. BMC Infect Dis. 2016 Jul 11;16:327. doi: 10.1186/s12879-016-1654-4. BMC Infect Dis. 2016. PMID: 27400781 Free PMC article.
Biochemical and hematologic parameters for children in the middle belt of Ghana.
Dosoo DK, Asante KP, Kayan K, Adu-Gyasi D, Osei-Kwakye K, Mahama E, Danso S, Amenga-Etego S, Bilson P, Koram KA, Owusu-Agyei S. Dosoo DK, et al. Am J Trop Med Hyg. 2014 Apr;90(4):767-73. doi: 10.4269/ajtmh.13-0098. Epub 2014 Mar 3. Am J Trop Med Hyg. 2014. PMID: 24591437 Free PMC article.
A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.
Ouédraogo A, Tiono AB, Kargougou D, Yaro JB, Ouédraogo E, Kaboré Y, Kangoye D, Bougouma EC, Gansane A, Henri N, Diarra A, Sanon S, Soulama I, Konate AT, Watson NL, Brown V, Hendriks J, Pau MG, Versteege I, Wiesken E, Sadoff J, Nebie I, Sirima SB. Ouédraogo A, et al. PLoS One. 2013 Nov 11;8(11):e78679. doi: 10.1371/journal.pone.0078679. eCollection 2013. PLoS One. 2013. PMID: 24244339 Free PMC article. Clinical Trial.
17 results